Metabolismo glicolítico mediado pela FTO na evasão imunitária do carcinoma papilar de células renais

envie a um amigo share this

Metabolismo glicolítico mediado pela FTO na evasão imunitária do carcinoma papilar de células renais

Sexta, 06.11.2026

Autores e Afiliações:

Catarina Guimarães-Teixeira a b c d, Sandra P. Nunes a b c e f, Alberto Bueno-Costa g, Laura Martinez-Verbo g, Iola F. Duarte h, Íris R. Carriço a b c d, Daniela Barros-Silva a b c, João Lobo a b c i j, Rui Henrique a b c i j, Manel Esteller g k l m, Vera Miranda-Gonçalves a b c i 1, Carmen Jerónimo a b c i 1

a Cancer Biology and Epigenetics Group, IPO Porto Research Center, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

b RISE Associate Laboratory (Health Research Network), Portugal

c Porto Comprehensive Cancer Centre Raquel Seruca (Porto.CCC Raquel Seruca), Porto, Portugal

d PhD Programme in Pathology & Molecular Genetics, ICBAS-School of Medicine & Biomedical Sciences-University of Porto, Porto, Portugal

e Molecular Oncology Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain

f Biomedical Research Institute I+12, University Hospital "12 de Octubre", Madrid, Spain

g Cancer Epigenetics Group, Josep Carreras Leukemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain

h Department of Chemistry, CICECO – Aveiro Institute of Materials and LAQV-REQUIMTE, University of Aveiro, Aveiro, Portugal

i Department of Pathology and Molecular Immunology, ICBAS-School of Medicine & Biomedical Sciences, University of Porto, Porto, Portugal

j Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal

k Centro de Investigación Biomedica en Red Cancer (CIBERONC), Madrid, Spain

l Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain

m Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain

1 Joint senior authors

 

Abstract:

N6-methyladenosine (m6A) methylation is the predominant internal modification in eukaryotic mRNA, characterized by the methylation of adenosine at the nitrogen-6 position. A key m6A demethylase, the Fat Mass and Obesity-associated protein (FTO) play a significant role in metabolism. Renal cell carcinoma (RCC), particularly papillary RCC, is characterized by increased glucose uptake and a shift towards anaerobic glycolysis, commonly known as the “Warburg effect”. This study investigates the role of FTO in glycolytic reprogramming and immune evasion in RCC. FTO disruption resulted in a Lactate Dehydrogenase A (LDHA) expression downregulation, followed by lactate production reduction and CD8 + T cells activation. Furthermore, FTO pharmacological inhibition by DAC51 promoted CD8 + T cell activation, also resulting in increased apoptotic activity. These findings reveal a novel role for FTO in regulating tumor metabolism and immune escape in pRCC, highlighting its potential as a therapeutic target for cancer immunotherapy.
 

Revista: Biomedicine & Pharmacotherapy

 

Link: https://www.sciencedirect.com/science/article/pii/S0753332226010450?via%3Dihub